World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
149
Citations
117599
World Ranking
123
National Ranking
80

Medicine

D-Index
149
Citations
117725
World Ranking
1177
National Ranking
684

Lieping Chen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lieping Chen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 515 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lieping Chen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lieping Chen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 149 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2017 - Warren Alpert Foundation Prize For their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment.
  • 2016 - AAI-Steinman Award for Human Immunology Research, American Association of Immunologists

Overview

Lieping Chen is affiliated with Yale University in the United States. Their research primarily spans the field of medicine, with a specific focus on oncology, immunology, pulmonary and respiratory medicine, molecular biology, and surgery. Chen's work concentrates on topics related to cancer immunotherapy, immune responses, and cell interactions within the immune system.

The main topics explored in Chen's research include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T Cell Therapy Research
  • Immune Cell Function and Interaction
  • Immune Cells in Cancer
  • Lung Cancer Treatments and Mutations
  • Glioma Diagnosis and Treatment

Chen has published extensively in several venues, with the most frequent publication outlets being:

  • IEEE Transactions on Systems Man and Cybernetics Systems
  • Journal of Thoracic Oncology
  • Journal of Investigative Dermatology
  • PubMed
  • Scientific Reports

Recent notable publications by Chen include:

  • Resistance Mechanisms to Anti-PD Cancer Immunotherapy, 2022, Annual Review of Immunology
  • Adaptive Immune Resistance at the Tumour Site: Mechanisms and Therapeutic Opportunities, 2022, Nature Reviews Drug Discovery
  • Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates, 2023, Journal of Clinical Oncology
  • A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy, 2021, Cancer Discovery
  • Blockade of the CD93 Pathway Normalizes Tumor Vasculature to Facilitate Drug Delivery and Immunotherapy, 2021, Science Translational Medicine

Frequent co-authors in Chen's research include:

  • Enrique Herrera-Viedma
  • Sam Kwong
  • Karen Panetta
  • Giancarlo Fortino
  • Róbert Kozma

Chen's contributions have been recognized by awards including the Warren Alpert Foundation Prize in 2017, awarded for collective contributions to the development of immune checkpoint blockade therapies in cancer treatment. In 2016, Chen also received the AAI-Steinman Award for Human Immunology Research from the American Association of Immunologists.

Best Publications

  • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

    Suzanne L. Topalian;F. Stephen Hodi;Julie R. Brahmer;Scott N. Gettinger

  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

    Tyler J Curiel;George Coukos;Linhua Zou;Xavier Alvarez

  • Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

    Haidong Dong;Scott E. Strome;Diva R. Salomao;Hideto Tamura

  • Molecular mechanisms of T cell co-stimulation and co-inhibition

    Lieping Chen;Dallas B. Flies;Dallas B. Flies

  • Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

    Julie R. Brahmer;Charles G. Drake;Ira Wollner;John D. Powderly

  • B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

    Haidong Dong;Gefeng Zhu;Koji Tamada;Lieping Chen

  • Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

    Janis M Taube;Alison P. Klein;Julie R Brahmer;Haiying Xu

  • PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

    Weiping Zou;Jedd D. Wolchok;Lieping Chen

  • Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

    Janis M. Taube;Robert A. Anders;Geoffrey D. Young;Haiying Xu

  • Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

    Unknown

  • Inhibitory B7-family molecules in the tumour microenvironment

    Weiping Zou;Lieping Chen

  • Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

    Lieping Chen

  • A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

    Miguel Fernández de Sanmamed;Lieping Chen

  • Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

    Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez

  • Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

    Lieping Chen;Xue Han

  • Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

    Lieping Chen;Stephanie Ashe;William A. Brady;Ingegerd Hellström

  • B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

    Andrei I. Chapoval;Jian Ni;Julie S. Lau;Ryan A. Wilcox

  • Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

    Fumiya Hirano;Katsumi Kaneko;Hideto Tamura;Haidong Dong

  • Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

    Ignacio Melero;Walter W. Shuford;Stephanie Ashe Newby;Alejandro Aruffo

  • Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

    Lieping Chen;Scott E. Strome;Eugene D. Kwon

  • Erratum: Molecular mechanisms of T cell co-stimulation and co-inhibition

    Lieping Chen;Dallas B. Flies

Frequent Co-Authors

Koji Tamada
Koji Tamada Yamaguchi University
Haidong Dong
Haidong Dong Mayo Clinic
Karl Erik Hellström
Karl Erik Hellström University of Washington
Kurt A. Schalper
Kurt A. Schalper Yale University
David L. Rimm
David L. Rimm Yale University
Roy S. Herbst
Roy S. Herbst Yale University
Ignacio Melero
Ignacio Melero University of Oxford
Weiping Zou
Weiping Zou University of Michigan–Ann Arbor
Ingegerd Hellström
Ingegerd Hellström University of Washington
Drew M. Pardoll
Drew M. Pardoll Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Nursing, in particular, offers several pathways that intersect with immunological knowledge, especially for those pursuing advanced practice roles.

Many nurses aim to enhance their qualifications by transitioning to specialized roles. For example, obtaining an acute care nurse practitioner certification enables practitioners to work with complex patient cases, including immunological disorders, in hospital or critical care settings.

Accelerated options exist for those seeking to fast-track their education. The accelerated NP program offers an efficient pathway for registered nurses to achieve nurse practitioner status, often with online flexibility, which is ideal for working professionals.

For individuals without a nursing background, pursuing an online ADN programs for non nurses provides foundational training necessary to enter the nursing profession and subsequently specialize further.

As advanced degrees are crucial for career advancement, understanding factors like the doctorate in nursing salary can help candidates make informed decisions about their educational investments and career goals.

Best Scientists Citing Lieping Chen

Trending Scientists

Recently Published Articles